Circulation: Heart Failure, Ahead of Print. BACKGROUND:Cardiac autoantibodies (cAAbs) are involved in the progression of adverse cardiac remodeling in heart
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:There is a paucity of data regarding epidemiology, temporal trends, and outcomes of patients
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Selecting high-risk patients with heart failure with potentially modifiable cardiovascular events is a priority.
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Patients with heart failure are vulnerable to the SARS-CoV-2 infection. However, limited evidence exists
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Heart failure is a prevailing diagnosis of hospitalization and readmission within 6 months, and
Read moreCirculation: Heart Failure, Ahead of Print. BACKGROUND:Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and has few treatments.
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Cardiovascular Quality and Outcomes, Ahead of Print. Source link
Read more
